ETF pharmaceuticals How to incorporate biotech and pharmaceutical values into the depot

  • Home
  • recommended
  • ETF pharmaceuticals How to incorporate biotech and pharmaceutical values into the depot
ETF pharmaceuticals How to incorporate biotech and pharmaceutical values into the depot
Images
  • By deutschewhiskybrenner
  • 723 Views

Processes as a sword of Damocles

There are also risks after a successful approval.Because occasionally there are serious side effects that people are severely damaged by health.Compensation for damages can burden companies and, in extreme cases, bring to the edge of the ruin.

ETF Pharmaaktien So bauen Sie Biotech- und Pharma-Werte ins Depot ein

Example Bayer.The German Bayer Group had to pay about $ 1.2 billion to settle the legal dispute over its medication Lipobay.Bayer had had to take the means of reducing cholesterol in 2001 due to dangerous side effects.

Example Wyeth.The damage to the US group Wyeth achieved a completely different size, which a wave of lawsuits cost around $ 22 billion due to two slimming means.Both companies ultimately gave way to these deep blows, but the consequences for the share prices were devastating.

Bayer's latest legal problems had nothing to do with medication, but with the weed destroyer glyphosate from his agricultural division.